亚太医疗第二意见市场预测至 2027 年 - COVID-19 影响及按疾病（癌症、骨科疾病、心脏疾病、神经系统疾病、肾病、血液系统疾病、慢性阻塞性肺病、器官移植等）和服务提供商进行的区域分析（医院、健康保险公司和在线服务）
No. of Pages: 113 | Report Code: TIPRE00025235 | Category: Life Sciences
No. of Pages: 113 | Report Code: TIPRE00025235 | Category: Life Sciences
医疗第二意见旨在提供有关患者当前治疗选择的有价值的信息。这一概念在处理因针对单个病例推荐各种治疗方案而造成的混乱方面发挥着重要作用。此外，还寻求该意见以获得更多信息，这有助于改善疾病的治疗结果。医学第二意见可以验证诊断；因此，它在提高治疗准确性方面发挥着重要作用。
亚太医疗第二意见市场预计将从2020年的77083万美元增至2027年的237450万美元；预计 2020 年至 2027 年复合年增长率为 17.4%。该市场的增长归因于全球远程医疗技术投资的增加和医疗咨询服务的数字化。然而，新兴国家缺乏意识并且不愿意选择医疗第二意见，可能会对预测期内的市场增长产生负面影响。
全球各地的患者正在目睹医疗保健服务带来的经济负担日益增加。由于医疗保健专业人员总体短缺和可用资源有限，医疗保健相关成本不断增加，因此需要在全球范围内优化医疗保健成本。此外，人们越来越重视降低额外成本，并且越来越意识到医疗机构可能会利用医疗机构，尤其是在低收入和中等收入国家，这极大地推动了医疗第二意见市场的发展。消费者可以从医疗第二意见中获取大量信息，同时就手术或主要病例做出必要的决定。此外，第二医疗意见提供者会根据额外的医疗诊断、现有医疗记录的分析以及对作为手术替代方案的其他治疗解决方案的评估来审查手术程序的建议。第二意见的这些方面可以导致治疗成本的降低。例如，根据世界卫生组织 2019 年发布的一项研究，全球约 25.0% 的患者患有外科手术并发症。医疗账单错误数量的增加也是导致市场增长的重要因素之一。预计到 2027 年，这些财务错误的可能性和发生将加速医疗第二意见市场的增长。此外，癌症患病率的增加，加上寻求第二意见的癌症患者数量的增加，将是重要因素之一在预测期内推动医疗第二意见市场的发展。
COVID-19 大流行已影响到亚太地区的多个国家。随着 COVID-19 疫情的蔓延，亚太地区大多数国家面临全面封锁，第二医疗意见成为必须。在印度，Foreign OPD——印度第一个也是唯一一个实现face2face第二医疗意见咨询的医疗保健品牌——将首次在印度为疑似感染COVID-19的人提供门诊和意识支持。该健康卡的推出是考虑到印度 COVID-19 危机期间调查和专家私人咨询成本不断上升。肺科医生和重症监护专家会为患者提供专门的治疗，这种咨询是理想的，甚至可以通过 Skype/电子邮件和电话与国际医生进行咨询（如果需要）以获得第二意见，无需额外费用。在印度医疗保健行业快速发展、越来越多的患者需要世界一流的专业知识和经验的情况下，这是该地区取得的里程碑，将为市场提供机遇。
根据疾病，亚太医疗第二意见市场细分为癌症、糖尿病、心脏疾病、神经系统疾病、肾病、血液疾病、慢性阻塞性肺病、骨科疾病、器官移植和其他疾病。癌症细分市场在 2019 年占据最大市场份额。然而，预计骨科疾病细分市场在预测期内的复合年增长率最高。
基于服务提供商，亚太医疗第二意见市场分为医院、健康保险公司和在线服务。 2019年，医院细分市场占据最大市场份额；然而，在线服务领域预计在预测期内的市场复合年增长率最高。
与本报告相关的主要和次要来源亚太医疗第二意见市场的权威机构包括印度品牌公平基金会 (IBEF)、印度卫生和家庭福利部 (MoHFW) 以及美国国立卫生研究院 (NIH)。
Strategic insights for Asia Pacific Medical Second Opinion involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2020 | US$ 770.83 Million |
| Market Size by 2027 | US$ 2,374.50 Million |
| Global CAGR (2020 - 2027) | 17.4% |
| Historical Data | 2018-2019 |
| Forecast period | 2021-2027 |
| Segments Covered |
By 疾病
|
| Regions and Countries Covered | 亚太地区
|
| Market leaders and key company profiles |
The regional scope of Asia Pacific Medical Second Opinion refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Asia Pacific Medical Second Opinion Market is valued at US$ 770.83 Million in 2020, it is projected to reach US$ 2,374.50 Million by 2027.
As per our report Asia Pacific Medical Second Opinion Market, the market size is valued at US$ 770.83 Million in 2020, projecting it to reach US$ 2,374.50 Million by 2027. This translates to a CAGR of approximately 17.4% during the forecast period.
The Asia Pacific Medical Second Opinion Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Medical Second Opinion Market report:
The Asia Pacific Medical Second Opinion Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Medical Second Opinion Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Medical Second Opinion Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Asia Pacific Medical Second Opinion Market
